Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07454798 · ClinicalTrials.gov registry record · NA

A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine

A NA study, sponsored by Children's Mercy Hospital Kansas City.

Recruiting
Registry status
NA
Development phase
38
Enrollment target

NCT07454798 is a NA study that is actively recruiting participants, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07454798, a NA study, is actively recruiting participants, sponsored by Children's Mercy Hospital Kansas City.

RECRUITING
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn whether a home-based virtual reality (VR) neurofeedback program is feasible and acceptable for adolescents with migraine. The study will also explore whether the program may improve headache-related outcomes. The main questions it aims to answer are: Is it feasible to enroll, randomize, and retain adolescents with migraine in this study? Do participants complete the VR sessions and study procedures as intended? Are there preliminary signals that the VR neurofeedback program may improve headache-related disability and symptoms? Researchers will compare Immersive Neurofeedback Self-Regulation Training (INSeRT), which uses brain activity recorded from a wearable electroencephalogram (EEG) headband to guide the VR experience, to a comparison VR program that presents immersive imagery without neurofeedback or guided relaxation training. Participants will: Complete a 4-week baseline period that includes headache logs, questionnaires, and a laboratory EEG assessment Be randomly assigned to one of two VR programs Complete VR sessions at home three times per week for 4 weeks Complete questionnaires at the end of treatment and again approximately 3 months later Repeat the laboratory EEG assessment at the end of treatment

Interventions

  • BEHAVIORAL Immersive Neurofeedback Self-Regulation Training (INSeRT)
  • BEHAVIORAL Virtual Reality Imagery (No Neurofeedback)

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2026-05-13
Est. Completion 2028-05-31
Phase NA

What the Registry Record Tells You About NCT07454798

The ClinicalTrials.gov registry entry for NCT07454798 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Immersive Neurofeedback Self-Regulation Training (INSeRT) is the first listed.

NCT07454798 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07454798 about?

NCT07454798 is a clinical study titled "A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine". The goal of this clinical trial is to learn whether a home-based virtual reality (VR) neurofeedback program is feasible and acceptable for adolescents with migraine. The study will also explore whether the program may improve headache-related outcomes. The main questions it aims to answer are: Is ...

What is the current status of trial NCT07454798?

This trial is currently recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2026-05-13. Estimated completion is 2028-05-31.

What interventions are being tested in trial NCT07454798?

The interventions under investigation include: Immersive Neurofeedback Self-Regulation Training (INSeRT) (BEHAVIORAL), Virtual Reality Imagery (No Neurofeedback) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07454798?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.